Valora Therapeutics

Target. Decoy. Engage Immunity.

La Jolla, United States · Founded 2023 · $30.0M raised

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M SeedNov 2024
Rounds
1

About

Valora Therapeutics is developing next-generation multispecific AbLec antibodies and T-Lec T cell engagers that decoy the glyco-immune checkpoint to create therapeutics for cancer and autoimmune disease. Founded in 2023 on technology invented in Carolyn Bertozzi's Stanford laboratory and exclusively licensed from Stanford, the privately held biotech initiated R&D operations in mid-2024 from its San Diego headquarters. The AbLec platform combines a tumor-targeting arm with a lectin decoy domain to remove glycan-mediated immune suppression, while T-Lec recruits T cells for more potent cancer-cell killing.

Summary

Valora Therapeutics is a Biotech company based in La Jolla, United States, founded in 2023. It has raised $30.0M in total across 1 round, most recently a $30.0M Seed round in Nov 2024. Investors include Avalon BioVentures, Bregua Corporation and TigerGene.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundNov 2024
$30.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Valora Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/valora-therapeutics"><img src="https://indexed.vc/api/badge/company/valora-therapeutics" alt="Valora Therapeutics on Indexed.vc" width="260" height="76" /></a>